Literature DB >> 991462

Comparative study of cyclophosphamide, 6-mercaptopurine, azathiopurine and methotrexate. Relative effects on the humoral and the cellular immune response in the mouse.

I G Otterness, Y H Chang.   

Abstract

The effects of cyclophosphamide, methotrexate, azathioprine and 6-mercaptopurine on the concomitant development of the humoral and the cellular immune responses of mice to a single antigen, the El4 tumour cell, were investigated. The measurements of cellular and humoral immunity were carried out in the same animal using lymphocyte and antibody mediated lysis of the El4 cell, a measurement system independent of underlying anti-inflammatory effects. A regimen of daily cyclophosphamide had a more pronounced suppressive effect on the humoral response than on the cellular response, in agreement with other investigators. A single low dose of cyclophosphamide stimulated the cellular response and suppressed the humoral response. Single or multiple high doses of cyclophosphamide maximally suppressed both the cellular and humoral response. Azathioprine and 6-mercaptopurine, in contrast to the results of other investigations, caused equivalent inhibition of both the humoral and cellular responses and thus lacked selectivity. Methotrexate also provided equivalent inhibition of both the humoral and cellular responses at all dose levels investigated.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 991462      PMCID: PMC1540853     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  APPLICATIONS OF ISO-IMMUNE CYTOLYSIS USING RADIOLABELLED TARGET CELLS.

Authors:  A R SANDERSON
Journal:  Nature       Date:  1964-10-17       Impact factor: 49.962

2.  INHIBITION OF IMMEDIATE AND DELAYED HYPERSENSITIVITY IN THE RABBIT BY 6-MERCAPTOPURINE.

Authors:  Y BOREL; R SCHWARTZ
Journal:  J Immunol       Date:  1964-05       Impact factor: 5.422

3.  Effect of 6-mercaptopurine on inflammation.

Authors:  A R PAGE; R M CONDIE; R A GOOD
Journal:  Am J Pathol       Date:  1962-05       Impact factor: 4.307

4.  Immunity to murine sarcoma virus-inducted tumors. II. Suppression of T cell-mediated immunity by cells from progressor animals.

Authors:  R M Gorczynski
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

5.  The effect of cyclophosphamide on the ontogeny of the humoral immune response in chickens.

Authors:  S P Lerman; W P Weidanz
Journal:  J Immunol       Date:  1970-09       Impact factor: 5.422

6.  Effects of azathioprine therapy on bone marrow-dependent and thymus-dependent cells in man.

Authors:  N I Abdou; B Zweiman; S R Casella
Journal:  Clin Exp Immunol       Date:  1973-01       Impact factor: 4.330

7.  Immunosuppression in the treatment of inflammatory bowel disease. I. Changes in lymphoid sub-populations in the blood and rectal mucosa following cessation of treatment with azathioprine.

Authors:  A C Campbell; J M Skinner; P Hersey; P Roberts-Thomson; I C MacLennan; S C Truelove
Journal:  Clin Exp Immunol       Date:  1974-04       Impact factor: 4.330

8.  Effect of azathioprine on in vitro antibody response. Differential effect on B cells involved in thymus-dependent and independent responses.

Authors:  P Galanaud; M C Crevon; J Dormont
Journal:  Clin Exp Immunol       Date:  1975-10       Impact factor: 4.330

9.  Differential effects of immunosuppressants on lymphocyte function.

Authors:  A Winkelstein
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

10.  Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.

Authors:  P W Askenase; B J Hayden; R K Gershon
Journal:  J Exp Med       Date:  1975-03-01       Impact factor: 14.307

View more
  10 in total

1.  Protein-anchoring strategy for delivering acetylcholinesterase to the neuromuscular junction.

Authors:  Mikako Ito; Yumi Suzuki; Takashi Okada; Takayasu Fukudome; Toshiro Yoshimura; Akio Masuda; Shin'ichi Takeda; Eric Krejci; Kinji Ohno
Journal:  Mol Ther       Date:  2012-02-28       Impact factor: 11.454

2.  Effects of 3,3',4,4'-tetrachloroazoxybenzene on selected immune parameters of the mouse.

Authors:  M R Bleavins; R D Hinsdill; J R Hochstein; M T Hsia
Journal:  Arch Environ Contam Toxicol       Date:  1985-11       Impact factor: 2.804

Review 3.  Immunomodulatory effects of cyclophosphamide and implementations for vaccine design.

Authors:  Antonella Sistigu; Sophie Viaud; Nathalie Chaput; Laura Bracci; Enrico Proietti; Laurence Zitvogel
Journal:  Semin Immunopathol       Date:  2011-05-25       Impact factor: 11.759

4.  A modified mouse air pouch model for evaluating the effects of compounds on granuloma induced cartilage degradation.

Authors:  K M Bottomley; R J Griffiths; T J Rising; A Steward
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

5.  Immune regulation of experimental myasthenia.

Authors:  S Fuchs; D Bartfeld; Z Eshhar; C Feingold; D Mochly-Rosen; D Novick; M Schwartz; R Tarrab-Hazdai
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

6.  A pharmacologic study of the relationship between lymphocyte function and surface antigen expression.

Authors:  M L Bliven; A C Cunningham; I G Otterness
Journal:  Agents Actions       Date:  1988-08

7.  Chlorozotocin, an anti-tumour agent lacking bone marrow toxicity at therapeutic doses: effects on lymphocyte subpopulations in mice.

Authors:  R I Fisher; G L Mandell; F Bostick; M G McMenamin; T Anderson
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

8.  Comparative activity of CP-17,193 and five established immunosuppressives toward the antigens SRBC and EL4.

Authors:  I G Otterness
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

Review 9.  Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer.

Authors:  L Bracci; G Schiavoni; A Sistigu; F Belardelli
Journal:  Cell Death Differ       Date:  2013-06-21       Impact factor: 15.828

10.  Analysis of synergy between cyclophosphamide therapy and immunity against a mouse tumour.

Authors:  D M Chassoux; F M Gotch; I C MacLennan
Journal:  Br J Cancer       Date:  1978-08       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.